nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—Upper gastrointestinal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0542	0.0632	CcSEcCtD
Capecitabine—TYMP—endothelium—focal segmental glomerulosclerosis	0.0399	0.279	CbGeAlD
Capecitabine—DPYD—nephron tubule—focal segmental glomerulosclerosis	0.0316	0.22	CbGeAlD
Capecitabine—DPYD—cortex of kidney—focal segmental glomerulosclerosis	0.027	0.189	CbGeAlD
Capecitabine—Tonsillitis—Cyclosporine—focal segmental glomerulosclerosis	0.0247	0.0289	CcSEcCtD
Capecitabine—Hyperkeratosis—Cyclosporine—focal segmental glomerulosclerosis	0.0219	0.0255	CcSEcCtD
Capecitabine—Polyneuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0192	0.0224	CcSEcCtD
Capecitabine—Pigmentation disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0187	0.0218	CcSEcCtD
Capecitabine—TYMS—nephron tubule—focal segmental glomerulosclerosis	0.0157	0.11	CbGeAlD
Capecitabine—TYMP—cortex of kidney—focal segmental glomerulosclerosis	0.0157	0.109	CbGeAlD
Capecitabine—Altered state of consciousness—Cyclosporine—focal segmental glomerulosclerosis	0.0135	0.0158	CcSEcCtD
Capecitabine—TYMS—cortex of kidney—focal segmental glomerulosclerosis	0.0134	0.0937	CbGeAlD
Capecitabine—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0153	CcSEcCtD
Capecitabine—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.0135	CcSEcCtD
Capecitabine—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0127	CcSEcCtD
Capecitabine—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0125	CcSEcCtD
Capecitabine—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0125	CcSEcCtD
Capecitabine—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0119	CcSEcCtD
Capecitabine—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00983	0.0115	CcSEcCtD
Capecitabine—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00973	0.0114	CcSEcCtD
Capecitabine—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00963	0.0112	CcSEcCtD
Capecitabine—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00953	0.0111	CcSEcCtD
Capecitabine—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00882	0.0103	CcSEcCtD
Capecitabine—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00859	0.01	CcSEcCtD
Capecitabine—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00829	0.00968	CcSEcCtD
Capecitabine—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00809	0.00944	CcSEcCtD
Capecitabine—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.00809	0.00944	CcSEcCtD
Capecitabine—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00802	0.00936	CcSEcCtD
Capecitabine—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00802	0.00936	CcSEcCtD
Capecitabine—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00796	0.00929	CcSEcCtD
Capecitabine—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00777	0.00907	CcSEcCtD
Capecitabine—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.00765	0.00893	CcSEcCtD
Capecitabine—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00696	0.00813	CcSEcCtD
Capecitabine—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00691	0.00807	CcSEcCtD
Capecitabine—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00687	0.00802	CcSEcCtD
Capecitabine—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00687	0.00802	CcSEcCtD
Capecitabine—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00678	0.00791	CcSEcCtD
Capecitabine—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00678	0.00791	CcSEcCtD
Capecitabine—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00673	0.00786	CcSEcCtD
Capecitabine—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00656	0.00766	CcSEcCtD
Capecitabine—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00656	0.00766	CcSEcCtD
Capecitabine—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00625	0.00729	CcSEcCtD
Capecitabine—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00607	0.00708	CcSEcCtD
Capecitabine—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00603	0.00704	CcSEcCtD
Capecitabine—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00596	0.00696	CcSEcCtD
Capecitabine—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00593	0.00692	CcSEcCtD
Capecitabine—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00586	0.00684	CcSEcCtD
Capecitabine—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00571	0.00666	CcSEcCtD
Capecitabine—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00565	0.00659	CcSEcCtD
Capecitabine—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00565	0.00659	CcSEcCtD
Capecitabine—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00545	0.00636	CcSEcCtD
Capecitabine—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00542	0.00633	CcSEcCtD
Capecitabine—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00542	0.00633	CcSEcCtD
Capecitabine—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00521	0.00608	CcSEcCtD
Capecitabine—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00519	0.00606	CcSEcCtD
Capecitabine—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00516	0.00603	CcSEcCtD
Capecitabine—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00512	0.00597	CcSEcCtD
Capecitabine—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00507	0.00592	CcSEcCtD
Capecitabine—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00507	0.00592	CcSEcCtD
Capecitabine—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00505	0.00589	CcSEcCtD
Capecitabine—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00502	0.00586	CcSEcCtD
Capecitabine—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.00571	CcSEcCtD
Capecitabine—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00485	0.00566	CcSEcCtD
Capecitabine—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00483	0.00563	CcSEcCtD
Capecitabine—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0048	0.00561	CcSEcCtD
Capecitabine—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00476	0.00556	CcSEcCtD
Capecitabine—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00474	0.00554	CcSEcCtD
Capecitabine—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0047	0.00549	CcSEcCtD
Capecitabine—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.00544	CcSEcCtD
Capecitabine—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00465	0.00542	CcSEcCtD
Capecitabine—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.0054	CcSEcCtD
Capecitabine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00453	0.00529	CcSEcCtD
Capecitabine—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.0045	0.00525	CcSEcCtD
Capecitabine—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00446	0.00521	CcSEcCtD
Capecitabine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.00501	CcSEcCtD
Capecitabine—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00425	0.00496	CcSEcCtD
Capecitabine—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00416	0.00485	CcSEcCtD
Capecitabine—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00414	0.00483	CcSEcCtD
Capecitabine—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.00478	CcSEcCtD
Capecitabine—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00401	0.00468	CcSEcCtD
Capecitabine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.004	0.00467	CcSEcCtD
Capecitabine—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00394	0.0046	CcSEcCtD
Capecitabine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00392	0.00457	CcSEcCtD
Capecitabine—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00385	0.0045	CcSEcCtD
Capecitabine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00382	0.00446	CcSEcCtD
Capecitabine—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00377	0.0044	CcSEcCtD
Capecitabine—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00376	0.00438	CcSEcCtD
Capecitabine—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.00428	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00364	0.00425	CcSEcCtD
Capecitabine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00357	0.00416	CcSEcCtD
Capecitabine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00355	0.00414	CcSEcCtD
Capecitabine—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.00413	CcSEcCtD
Capecitabine—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00351	0.0041	CcSEcCtD
Capecitabine—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.00408	CcSEcCtD
Capecitabine—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.00408	CcSEcCtD
Capecitabine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00348	0.00407	CcSEcCtD
Capecitabine—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00344	0.00402	CcSEcCtD
Capecitabine—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00343	0.00401	CcSEcCtD
Capecitabine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00342	0.004	CcSEcCtD
Capecitabine—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00342	0.004	CcSEcCtD
Capecitabine—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00341	0.00398	CcSEcCtD
Capecitabine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00341	0.00398	CcSEcCtD
Capecitabine—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.0034	0.00396	CcSEcCtD
Capecitabine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0034	0.00396	CcSEcCtD
Capecitabine—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.00389	CcSEcCtD
Capecitabine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.00386	CcSEcCtD
Capecitabine—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.00385	CcSEcCtD
Capecitabine—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.00368	CcSEcCtD
Capecitabine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.00367	CcSEcCtD
Capecitabine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.00366	CcSEcCtD
Capecitabine—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.00366	CcSEcCtD
Capecitabine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00312	0.00364	CcSEcCtD
Capecitabine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00311	0.00363	CcSEcCtD
Capecitabine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.00362	CcSEcCtD
Capecitabine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.0036	CcSEcCtD
Capecitabine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.00359	CcSEcCtD
Capecitabine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00302	0.00353	CcSEcCtD
Capecitabine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.00341	CcSEcCtD
Capecitabine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00291	0.0034	CcSEcCtD
Capecitabine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00285	0.00332	CcSEcCtD
Capecitabine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.0033	CcSEcCtD
Capecitabine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00328	CcSEcCtD
Capecitabine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.00327	CcSEcCtD
Capecitabine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00277	0.00324	CcSEcCtD
Capecitabine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.00321	CcSEcCtD
Capecitabine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00273	0.00319	CcSEcCtD
Capecitabine—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00269	0.00314	CcSEcCtD
Capecitabine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00267	0.00312	CcSEcCtD
Capecitabine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.00306	CcSEcCtD
Capecitabine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.003	CcSEcCtD
Capecitabine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.00299	CcSEcCtD
Capecitabine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.00296	CcSEcCtD
Capecitabine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00295	CcSEcCtD
Capecitabine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.00287	CcSEcCtD
Capecitabine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00286	CcSEcCtD
Capecitabine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00285	CcSEcCtD
Capecitabine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.00278	CcSEcCtD
Capecitabine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.00275	CcSEcCtD
Capecitabine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.00271	CcSEcCtD
Capecitabine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.00271	CcSEcCtD
Capecitabine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.00271	CcSEcCtD
Capecitabine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.0027	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.00269	CcSEcCtD
Capecitabine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.00268	CcSEcCtD
Capecitabine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00265	CcSEcCtD
Capecitabine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00262	CcSEcCtD
Capecitabine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.0026	CcSEcCtD
Capecitabine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.00258	CcSEcCtD
Capecitabine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.00255	CcSEcCtD
Capecitabine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00218	0.00255	CcSEcCtD
Capecitabine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00253	CcSEcCtD
Capecitabine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.00251	CcSEcCtD
Capecitabine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00248	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00237	CcSEcCtD
Capecitabine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00235	CcSEcCtD
Capecitabine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00234	CcSEcCtD
Capecitabine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00232	CcSEcCtD
Capecitabine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.00229	CcSEcCtD
Capecitabine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00226	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00225	CcSEcCtD
Capecitabine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00224	CcSEcCtD
Capecitabine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00222	CcSEcCtD
Capecitabine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00222	CcSEcCtD
Capecitabine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00214	CcSEcCtD
Capecitabine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00213	CcSEcCtD
Capecitabine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00207	CcSEcCtD
Capecitabine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00206	CcSEcCtD
Capecitabine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00206	CcSEcCtD
Capecitabine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00192	CcSEcCtD
Capecitabine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00187	CcSEcCtD
Capecitabine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00184	CcSEcCtD
Capecitabine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.00178	CcSEcCtD
Capecitabine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00172	CcSEcCtD
Capecitabine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00165	CcSEcCtD
Capecitabine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00164	CcSEcCtD
Capecitabine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00164	CcSEcCtD
Capecitabine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00163	CcSEcCtD
Capecitabine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00154	CcSEcCtD
